Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Disulfiram (DSF), an established alcohol‐aversion drug, is a candidate for repurposing in cancer treatment. DSF’s antitumor activity is supported by preclinical studies, case reports, and small clinical trials; however, ongoing clinical trials of advanced‐stage cancer patients encounter variable res...

Full description

Bibliographic Details
Main Authors: Tereza Buchtova, Zdenek Skrott, Katarina Chroma, Jiri Rehulka, Petr Dzubak, Marian Hajduch, David Lukac, Stefanos Arampatzis, Jiri Bartek, Martin Mistrik
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Molecular Oncology
Subjects:
cancer
cannabidiol
CuET
disulfiram
metallothionein
Online Access:https://doi.org/10.1002/1878-0261.13114

Internet

https://doi.org/10.1002/1878-0261.13114

Similar Items